A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 4,710 shares of TMDX stock, worth $300,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,710
Previous 5,262 10.49%
Holding current value
$300,969
Previous $792,000 6.69%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $74,895 - $97,212
-552 Reduced 10.49%
4,710 $739,000
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $35,075 - $72,749
483 Added 10.11%
5,262 $792,000
Q1 2024

May 14, 2024

BUY
$70.86 - $89.93 $338,639 - $429,775
4,779 New
4,779 $353,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.03B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.